1. Home
  2. HLIO vs AGIO Comparison

HLIO vs AGIO Comparison

Compare HLIO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helios Technologies Inc.

HLIO

Helios Technologies Inc.

HOLD

Current Price

$83.04

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$32.41

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIO
AGIO
Founded
1970
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
HLIO
AGIO
Price
$83.04
$32.41
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$66.17
$38.88
AVG Volume (30 Days)
255.3K
1.1M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
0.72%
N/A
EPS Growth
23.93
N/A
EPS
0.59
N/A
Revenue
$200,727,000.00
$43,011,000.00
Revenue This Year
$3.67
$76.75
Revenue Next Year
$5.00
$170.73
P/E Ratio
$139.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.05
$22.24
52 Week High
$95.05
$46.00

Technical Indicators

Market Signals
Indicator
HLIO
AGIO
Relative Strength Index (RSI) 54.67 38.40
Support Level $78.81 $26.71
Resistance Level $83.99 $36.07
Average True Range (ATR) 2.60 2.01
MACD 0.46 -0.85
Stochastic Oscillator 75.89 24.67

Price Performance

Historical Comparison
HLIO
AGIO

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: